Expleo Solutions DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.77×0.76×0.74×0.76×0.72×
1.16×1.15×1.10×1.04×1.08×
13.5%12.8%12.3%11.9%19.1%
1.26×1.26×1.28×1.29×1.68×
1.20×1.20×1.31×1.25×1.38×
18.2%16.9%16.9%15.1%34.3%
19.9%19.9%16.6%15.9%34.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

EXPLEOSOL₹808.00

Expleo Solutions Limited

· Technology
₹ CrorePeersDSSLDIGITIDECEINSYSIZMOORIENTTECHAURUMBCGGENESYSMcap ₹1,254 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.720.760.740.760.77
Interest Burden (Pretax/EBIT) ×1.081.041.101.151.16
EBIT Margin %19.0711.8812.3312.7813.45
Asset Turnover ×1.681.291.281.261.26
Financial Leverage (Assets/Equity) ×1.381.251.311.201.20
ROE (5-step product, year-end total equity) %34.2915.1316.8516.8718.22
ROE (owners' profit / average owners' equity) %34.0915.8516.5619.8919.89
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.